Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Top Cited Papers
- 5 April 2008
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (9) , 2589-2599
- https://doi.org/10.1021/jm0704090
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007
- Proteins: is the folding process dynamically encoded?Soft Matter, 2007
- A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 daysBritish Journal of Cancer, 2006
- Discovery of protein phosphatase inhibitor classes by biology-oriented synthesisProceedings of the National Academy of Sciences, 2006
- Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical TrialsAccounts of Chemical Research, 2003
- The structure of the protein universe and genome evolutionNature, 2002
- Dimerization of the Insulin-like Growth Factor II/Mannose 6-Phosphate ReceptorPublished by Elsevier ,2000
- New 4-Point Pharmacophore Method for Molecular Similarity and Diversity Applications: Overview of the Method and Applications, Including a Novel Approach to the Design of Combinatorial Libraries Containing Privileged SubstructuresJournal of Medicinal Chemistry, 1999
- Characterization and Expression of a Novel Human Fatty Acid-Binding Protein: The Epidermal Type (E-FABP)Biochemical and Biophysical Research Communications, 1993
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJournal of Antimicrobial Chemotherapy, 1988